Literature DB >> 2899369

Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function.

S Larsen1, J Hilsted, B Tronier, H Worning.   

Abstract

Hormonal responses (glucagon, pancreatic polypeptide and somatostatin) to iv glucagon, iv arginine, and ingestion of a mixed meal were investigated in 6 patients with insulin-dependent diabetes secondary to chronic pancreatitis without beta-cell function, in 8 Type I (insulin-dependent) diabetics without beta-cell function, and 8 healthy subjects. No significant differences were found between the two diabetic groups regarding glucagon responses to arginine and meal ingestion. In the patients with diabetes secondary to chronic pancreatitis compared with Type I diabetics and normal controls, the pancreatic polypeptide concentrations were significantly lower and somatostatin concentrations were significantly higher after glucagon, arginine and a mixed meal. Thus, pancreatic glucagon secretion was preserved in patients with insulin-dependent diabetes secondary to chronic pancreatitis, having no residual beta-cell function. These findings suggest that pancreatic glucagon deficiency is not absolute in insulin-dependent diabetes secondary to chronic pancreatitis. A high level of somatostatin may contribute to a lower blood glucose level in patients with chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899369     DOI: 10.1530/acta.0.1180357

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  16 in total

1.  Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans.

Authors:  J J Meier; T G K Breuer; R C Bonadonna; A Tannapfel; W Uhl; W E Schmidt; H Schrader; B A Menge
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

2.  Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012.

Authors:  Michael R Rickels; Melena Bellin; Frederico G S Toledo; R Paul Robertson; Dana K Andersen; Suresh T Chari; Randall Brand; Luca Frulloni; Michelle A Anderson; David C Whitcomb
Journal:  Pancreatology       Date:  2013-05-17       Impact factor: 3.996

3.  Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis.

Authors:  T Nakamura; K Imamura; K Takebe; A Terada; Y Arai; Y Tandoh; N Yamada; M Ishii; K Machida; T Suda
Journal:  Int J Pancreatol       Date:  1996-12

Review 4.  β-Cell dysfunction in chronic pancreatitis.

Authors:  M Sasikala; R Talukdar; P Pavan kumar; G Radhika; G V Rao; R Pradeep; C Subramanyam; D Nageshwar Reddy
Journal:  Dig Dis Sci       Date:  2012-03-02       Impact factor: 3.199

Review 5.  Diagnosis and treatment of diabetes mellitus in chronic pancreatitis.

Authors:  Nils Ewald; Philip D Hardt
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.

Authors:  Dana K Andersen; Åke Andren-Sandberg; Eric J Duell; Michael Goggins; Murray Korc; Gloria M Petersen; Jill P Smith; David C Whitcomb
Journal:  Pancreas       Date:  2013-11       Impact factor: 3.327

Review 7.  [Diagnosis and therapy of chronic pancreatitis].

Authors:  R Mahlke; H Lübbers; P G Lankisch
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

8.  Chronic Pancreatitis and Diabetes Mellitus.

Authors:  Yu Kuei Lin; Philip C Johnston; Karla Arce; Betul A Hatipoglu
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

9.  Preservation of somatostatin secretion in cystic fibrosis patients with diabetes.

Authors:  L R Meacham; D B Caplan; L P McKean; C N Buchanan; J S Parks; F L Culler
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

Review 10.  A tale of two pancreases: exocrine pathology and endocrine dysfunction.

Authors:  Michael R Rickels; Andrew W Norris; Rebecca L Hull
Journal:  Diabetologia       Date:  2020-09-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.